Title :

Adjustable Continence Therapy (ACT®) balloons to treat female stress urinary incontinence: effectiveness, safety and risk factors of failure and complication.

Author(s) :

De Guerry, Marie-Liesse [Auteur]
Service d'Urologie, andrologie et transplantation rénale [CHRU Lille]
Demeestere, Amélie [Auteur]
Service d'Urologie, andrologie et transplantation rénale [CHRU Lille]
Bergot, Christophe [Auteur]
Centre Hospitalier Universitaire de Nantes = Nantes University Hospital [CHU Nantes]
De Hauteclocque, Astrid [Auteur]
service d'urologie [CHU Bordeaux]
Hascoet, Juliette [Auteur]
Service d'urologie [Rennes] = Urology [Rennes]
Ternynck, Camille [Auteur]
Service de Biostatistiques [CHRU Lille]
Gamelin, Francois-Xavier [Auteur]
Département d'Urologie-Andrologie et Transplantation Rénale [CHU Toulouse]
Peyronnet, Benoît [Auteur]
Service d'urologie [Rennes] = Urology [Rennes]
Capon, Grégoire [Auteur]
service d'urologie [CHU Bordeaux]
Perrouin-Verbe, Marie-Aimée [Auteur]
Centre Hospitalier Universitaire de Nantes = Nantes University Hospital [CHU Nantes]
Biardeau, Xavier [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Service d'Urologie, andrologie et transplantation rénale [CHRU Lille]
Lille Neurosciences & Cognition - U 1172 [LilNCog]

Journal title :

International Urogynecology Journal

Abbreviated title :

Int Urogynecol J

Publication date :

2022-07-02

ISSN :

1433-3023

English keyword(s) :

Compression device
Intrinsic sphincter deficiency
Women
Urinary incontinence

HAL domain(s) :

Sciences du Vivant [q-bio]

English abstract : [en]

Introduction and hypothesis To assess the effectiveness, safety and risk factors of failure and complications associated with Adjustable Continence Therapy (ACT®) balloons as a treatment for female stress urinary incontinence ...
Show more >Introduction and hypothesis To assess the effectiveness, safety and risk factors of failure and complications associated with Adjustable Continence Therapy (ACT®) balloons as a treatment for female stress urinary incontinence (SUI). Methods In the present multicentric retrospective study, all women implanted with ACT® balloons between 2000 and 2018 were considered eligible. Effectiveness and safety were assessed at 1 year, and risk factors for failure and complications were sought. The effectiveness was categorized into three distinct groups: Success = maximum 1 pad/day and patient’s impression of improvement using a numerical rating scale (NRS) ≥ 8/10; Improvement = decrease of daily pad use and NRS ≥ 5/10; Failure = increase or stability of daily pad use or NRS < 5/10. The intra- and postoperative surgical complications were collected. Results Over the study period, 281 women were included. Among them, 104 (37.0%), 94 (33.5%) and 83 (29.5%) were categorized as success, improvement, and failure, respectively. Intra-, early and late postoperative complications occurred in 13 (4.6%), 35 (12.5%) and 75 (26.7%) women, respectively. Most early surgical complications were minor according to the Dindo-Clavien classification. Of women that presented a late postoperative surgical complication, 64 (22.8%) underwent an explantation performed under local or general anesthesia without associated sequalae. Conclusions The short-term effectiveness associated with ACT® balloons, their minimally invasive implantation and the frequent but easily manageable and sequelae-free complications suggest that they should be part of the therapeutic arsenal for female SUI. Keywords Compression device · Intrinsic sphincter deficiency · Women · Urinary incontinenceShow less >

Language :

Anglais

Audience :

Internationale

Popular science :

Non

Administrative institution(s) :

Université de Lille
CHU Lille

Collections :

• METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694

Submission date :

2023-11-15T03:48:38Z
2024-01-19T08:42:32Z